Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Defensive Interval Ratio

Latest as of March 2026: 165 days

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Defensive Interval Ratio of 165 days as of March 2026. Defensive assets of €1.28 Billion (cash €-, short-term investments €-, receivables €1.28 Billion) cover 165 days of daily cash needs of €7.75 Million/day. Check how tangible is Tianjin Zhong Xin Pharmaceutical Group C's equity to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

165 days
Days of operational coverage

Defensive Assets

€1.28 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€7.75 Million
Current Liabilities ÷ 365

Current Liabilities

€2.83 Billion
EUR

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Defensive Interval Ratio (2013–2025)

This chart shows how Tianjin Zhong Xin Pharmaceutical Group Corporation Limited's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 165 days, meaning defensive assets of €1.28 Billion can fund 165 days of operations without new revenue. Also explore Tianjin Zhong Xin Pharmaceutical Group C equity growth rate to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)

The table below presents the year-by-year Defensive Interval Ratio for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Tianjin Zhong Xin Pharmaceutical Group C (2TZ) total market value.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 79 days €973.20 Million €12.35 Million/day €- €- ▼ -19 days
2024 98 days €756.29 Million €7.72 Million/day €- €- ▼ -147 days
2023 245 days €2.17 Billion €8.86 Million/day €- €- ▲ +10 days
2022 235 days €2.15 Billion €9.13 Million/day €- €- ▲ +5 days
2021 230 days €1.54 Billion €6.67 Million/day €- €- ▼ -25 days
2020 255 days €1.51 Billion €5.93 Million/day €- €- ▼ -58 days
2019 313 days €1.85 Billion €5.91 Million/day €- €43.52 Million ▼ -26 days
2018 340 days €1.78 Billion €5.24 Million/day €- €53.31 Million ▲ +18 days
2017 322 days €1.64 Billion €5.10 Million/day €- €100.50 Million ▲ +44 days
2016 277 days €1.50 Billion €5.39 Million/day €- €660.00K ▼ -67 days
2015 345 days €1.74 Billion €5.04 Million/day €- €200.00 Million ▲ +83 days
2014 262 days €1.69 Billion €6.47 Million/day €- €- ▲ +26 days
2013 236 days €1.65 Billion €6.99 Million/day €- €- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)